$46.17
-0.56%CNO Financial Group, Inc., through its subsidiaries, develops, markets, and administers health insurance, annuity, individual life insurance, and other insurance products for senior and middle-income markets in the United States. It offers Medicare supplement, supplemental health, and long-term care insurance policies; life insurance; and annuities, as well as Medicare advantage plans to individuals through phone, online, mail, and face-to-face. The company also focuses on worksite and group sales for businesses, associations, and other membership groups by interacting with customers at their place of employment. In addition, it provides fixed index annuities; fixed interest annuities, including fixed rate single and flexible premium deferred annuities; single premium immediate annuities; supplemental health products, such as specified disease, accident, and hospital indemnity products; and long-term care plans primarily to retirees and older self-employed individuals in the middle-income market. Further, the company offers universal life and other interest-sensitive life products; and traditional life policies that include whole life, graded benefit life, term life, and single premium whole life products, as well as graded benefit life insurance products. CNO Financial Group, Inc. markets its products under the Bankers Life, Washington National, and Colonial Penn brand names. The company sells its products through agents, independent producers, and direct marketing. CNO Financial Group, Inc. was founded in 1979 and is headquartered in Carmel, Indiana.
Strong gross margins indicate healthy pricing and efficient production or service delivery.
Acceptable margins but limited operational leverage. Operating expense control is important.
Moderate profitability with room for improvement. Monitor interest expenses and tax efficiency.
Moderate tax rate typical for most corporations. Represents standard tax burden on profits.
Margin squeeze alert: Healthy gross margins but weak operating margins suggest excessive operating expenses. Cost optimization could unlock significant value.
CNO โข NYSE
| CNO Financial Group, Inc. Income Statement | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | Dec 2007 | Dec 2006 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
REVENUE | ||||||||||||||||||||
4.5B | 4.4B | 4.1B | 3.6B | 4.1B | 3.8B | 4B | 4.3B | 4.3B | 4B | 3.8B | 4.1B | 4.5B | 4.3B | 4.1B | 4.1B | 4.3B | 4.2B | 4.1B | 4.5B | |
GROSS PROFIT | ||||||||||||||||||||
(2.5B) | (2.7B) | (2.6B) | (1.8B) | (2.4B) | (2.5B) | (2.8B) | (3.7B) | (3B) | (2.8B) | (2.7B) | (2.9B) | (3.2B) | (3.2B) | (3.1B) | (3.2B) | (3.6B) | (3.7B) | (2.9B) | (6.2B) | |
2B | 1.7B | 1.5B | 1.8B | 1.7B | 1.3B | 1.2B | 580.2M | 1.3B | 1.2B | 1.1B | 1.2B | 1.2B | 1.2B | 996.5M | 857.3M | 746.4M | 456.9M | 1.2B | -1.8B | |
OPERATING INCOME | ||||||||||||||||||||
(1.7B) | (1.2B) | (1.2B) | (973.7M) | (966.3M) | (939M) | (958.9M) | (845M) | (863.4M) | (809.5M) | (751.8M) | (1B) | (931.5M) | (1B) | (690.3M) | (563.8M) | (572.8M) | (453.2M) | (1.2B) | -1.9B | |
(0.0) | (304.5M) | (290.9M) | (287.9M) | (267.9M) | (252.6M) | (238.2M) | (233.2M) | (237.3M) | (231M) | (205.2M) | (242.4M) | (234M) | (226.6M) | (212.2M) | (0.0) | (0.0) | (0.0) | (64.4M) | (184M) | |
293.4M | 518.3M | 356.8M | 816.5M | 733.1M | 344.3M | 274.2M | -264.8M | 480.5M | 353.2M | 367.7M | 175.1M | 304.8M | 155.7M | 306.2M | 293.5M | 173.6M | 3.7M | -10M | 167.2M | |
PRE-TAX INCOME | ||||||||||||||||||||
(230.9M) | (254.4M) | (238.6M) | (137M) | (95.4M) | (108.8M) | (152.3M) | (149.8M) | (123.7M) | (116.4M) | (94.9M) | (92.8M) | (105.3M) | (114.6M) | (114.1M) | (113.2M) | (117.9M) | (106.5M) | (117.3M) | (73.5M) | |
-230.9M | -254.4M | -238.6M | -137M | -95.4M | -108.8M | -152.3M | -149.8M | -123.7M | -116.4M | -94.9M | -92.8M | -105.3M | -114.6M | -114.1M | -113.2M | -117.9M | -106.5M | -117.3M | -73.5M | |
(1.7B) | (879.5M) | (884.9M) | (685.8M) | (698.4M) | (686.4M) | (720.7M) | (611.8M) | (626.1M) | (578.5M) | (546.6M) | (794.2M) | (697.5M) | (791.7M) | (478.1M) | (563.8M) | (572.8M) | (453.2M) | (1.2B) | -2.1B | |
293.4M | 518.3M | 356.8M | 816.5M | 733.1M | 344.3M | 274.2M | -264.8M | 480.5M | 353.2M | 367.7M | 175.1M | 304.8M | 155.7M | 306.2M | 293.5M | 173.6M | 3.7M | -10M | 167.2M | |
NET INCOME | ||||||||||||||||||||
(64.1M) | (114.3M) | (80.3M) | (185.9M) | (162.8M) | (42.5M) | -135.2M | (50.2M) | (304.9M) | -5M | (97M) | (123.7M) | -173.2M | -65.3M | -29.5M | (8.9M) | (87.9M) | (413.3M) | (64M) | (61.2M) | |
229.3M | 404M | 276.5M | 630.6M | 570.3M | 301.8M | 409.4M | -315M | 175.6M | 358.2M | 270.7M | 51.4M | 478M | 221M | 335.7M | 284.6M | 85.7M | -1.1B | -179.9M | 106M |
CNO - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
8-K 8-K 2026 N/A | May 13, 2026 | May 12, 2026 | 2026 | |
10-Q 10-Q 2026 Q1 Q1 | May 07, 2026 | March 31, 2026 | 2026 | |
8-K 8-K 2026 N/A | April 30, 2026 | April 30, 2026 | 2026 | |
DEF 14A DEF 14A 2026 N/A | March 26, 2026 | March 26, 2026 | 2026 | |
10-K 10-K 2025 FY FY | February 24, 2026 | December 31, 2025 | 2025 | |
8-K 8-K 2026 N/A | February 11, 2026 | February 10, 2026 | 2026 | |
8-K 8-K 2026 N/A | February 05, 2026 | February 05, 2026 | 2026 | |
8-K 8-K 2026 N/A | January 15, 2026 | January 15, 2026 | 2026 | |
10-Q 10-Q 2025 Q3 Q3 | November 06, 2025 | September 30, 2025 | 2025 | |
8-K 8-K 2025 N/A | November 03, 2025 | November 03, 2025 | 2025 |
Continue your CNO research with focused valuation guides.
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.